| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/03/1994 | WO1994002608A1 Process for obtaining antibodies |
| 02/03/1994 | WO1994002607A1 Protein expression system |
| 02/03/1994 | WO1994002604A1 RECOMBINANT CDw52 ANTIGEN |
| 02/03/1994 | WO1994002602A1 Generation of xenogeneic antibodies |
| 02/03/1994 | WO1994002596A1 Method for preventing zoster or alleviating varicella related post-herpetic neuralgia |
| 02/03/1994 | WO1994002593A1 Mammalian multipotent neural stem cells |
| 02/03/1994 | WO1994002592A1 Animal cell culture |
| 02/03/1994 | WO1994002589A1 Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity |
| 02/03/1994 | WO1994002512A1 Carboxy terminal il-6 muteins |
| 02/03/1994 | WO1994002510A2 Analogs of pth |
| 02/03/1994 | WO1994002175A1 Alleviation of symptoms associated with inflammatory disease states |
| 02/03/1994 | WO1994002169A1 Vaccines against metazoan parasites |
| 02/03/1994 | WO1994002167A1 p53 VACCINE |
| 02/03/1994 | WO1993021321A3 T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA) |
| 02/03/1994 | WO1993021303A3 Enhanced purification and expression of insoluble recombinant proteins |
| 02/03/1994 | DE4227454C1 Verfahren zur Früherkennung, zur Erkennung des Schweregrads sowie zur therapiebegleitenden Verlaufsbeurteilung einer Sepsis sowie Mittel zur Durchführung des Verfahrens Methods for early detection, to detect the severity and therapy-accompanying assessment of sepsis and means for carrying out the method |
| 02/03/1994 | DE4225038A1 Herstellung und Verwendung von Antikörpern gegen Kollagen Preparation and use of antibodies against collagen |
| 02/03/1994 | CA2140884A1 Mammalian multipotent neural stem cells |
| 02/03/1994 | CA2140673A1 Vaccines against metazoan parasites |
| 02/03/1994 | CA2140151A1 Peptides that mimic gp120 hiv epitope |
| 02/03/1994 | CA2140132A1 Carboxy terminal il-6 muteins |
| 02/03/1994 | CA2139410A1 Diagnostic method |
| 02/03/1994 | CA2139333A1 Clinical test for detection of alzheimer's disease |
| 02/03/1994 | CA2137558A1 Method of intracellular binding of target molecules |
| 02/02/1994 | EP0581353A1 Monoclonal antibodies to HiV-1 gp120, cell lines producing them and corresponding epitope structures |
| 02/02/1994 | EP0581108A2 Bispecific antibody reactive with sialyl-Lea antigen and CD3 |
| 02/02/1994 | EP0580859A1 Anti-eda monoclonal antibody |
| 02/02/1994 | EP0580829A1 Bacterial protein extract, process for preparing the same and pharmaceutical composition containing said extract |
| 02/02/1994 | EP0580782A1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof. |
| 02/02/1994 | EP0580758A1 Anti-human immunodeficiency virus recombinant antibodies |
| 02/02/1994 | EP0580737A1 Heterodimeric receptor libraries using phagemids |
| 02/02/1994 | EP0580694A1 Production of phosphopeptides from casein |
| 02/02/1994 | EP0580649A1 Plant promoter involved in controlling lipid biosynthesis in seeds |
| 02/02/1994 | EP0580621A1 Nucleic acid fragment of the x chromosome region involved in the fragile x syndrome, nucleotide probe and method of diagnosing mental retardation with fragile x |
| 02/02/1994 | EP0580596A1 Gene mutated in colorectal cancer of humans |
| 02/02/1994 | EP0290446B1 Vaccines for human respiratory virus |
| 02/02/1994 | EP0289597B1 Eucaryotic expression system |
| 02/02/1994 | EP0246307B1 Cys codon-modified dna |
| 02/02/1994 | EP0211047B1 Arab promoters and method of producing polypeptides, includinn cecropins, by microbiological techniques |
| 02/02/1994 | CN1081379A Human placental Collagen and the prepn. thereof |
| 02/01/1994 | US5283191 Mareks' disease virus vaccine |
| 02/01/1994 | US5283190 Specific monoclonal antibodies against a defined epitope of progesterone receptor and methods for their use |
| 02/01/1994 | US5283172 Type-C rotavirus cultures and uses therefor |
| 01/31/1994 | CA2101468A1 Composition for isolating apamin receptors, apamin binding protein, and uses thereof |
| 01/30/1994 | CA2101348A1 Biologically active porcine somatotropin polypeptides and methods of using the same |
| 01/27/1994 | DE4324276A1 Asparaginyl-Endoprotease, Verfahren zu ihrer Herstellung und ihre Verwendung Asparaginyl endoprotease, processes for their preparation and their use |
| 01/26/1994 | EP0579758A1 Parathyroid hormone receptor and dna encoding same |
| 01/26/1994 | EP0579739A1 Interleukin-8 receptors and related molecules and methods |
| 01/26/1994 | EP0579640A1 Glial mitogenic factors, their preparation and use |
| 01/26/1994 | EP0579626A1 Method and agents for promoting wound healing |
| 01/26/1994 | EP0579621A1 PROTEIN PRODUCTION FROM IMMORTAL CELLS GROWN $i(IN VIVO) |
| 01/26/1994 | EP0424512B1 Antimetastatic peptides |
| 01/26/1994 | EP0419504B1 Insulin analogues |
| 01/26/1994 | EP0409883B1 Monoclonal antibody to enteroviruses |
| 01/26/1994 | EP0366684B1 Ibdv vp2 epitope recognised by virus neutralising and protective monoclonal antibodies |
| 01/26/1994 | EP0272304B1 A process for producing a coagulation active complex of factor viii fragments |
| 01/25/1994 | US5281661 Contacting aqueous conductive mixture with carrier based on a polymer containing hydrophobic groups to complex factor XI |
| 01/25/1994 | US5281525 Cephalosporin acetylhydrolase gene from Bacillus subtilis |
| 01/25/1994 | CA1326459C Diagnostic peptides of human papilloma virus |
| 01/20/1994 | WO1994028021A1 Endometrial proteins, antigenic compositions and methods for detecting endometriosis |
| 01/20/1994 | WO1994001777A1 Method of determining metastatic potential of tumor cells |
| 01/20/1994 | WO1994001570A1 K. lactis rp28 ribosomal protein gene promoter and use thereof |
| 01/20/1994 | WO1994001569A1 K. lactis pyruvate-decarboxylase promoter gene and use thereof |
| 01/20/1994 | WO1994001558A2 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 01/20/1994 | WO1994001556A1 Polypeptides having serotoninergic receptor activity (5ht6), nucleic acids coding for said polypeptides, and uses thereof |
| 01/20/1994 | WO1994001554A1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |
| 01/20/1994 | WO1994001553A1 Receptor derivates with binding sites for human rhinoviruses |
| 01/20/1994 | WO1994001552A1 Target antigens of transmission blocking antibodies for malaria parsites |
| 01/20/1994 | WO1994001548A2 Human nucleic acid fragments, isolated from brain adrenal tissue, placenta or bone narrow |
| 01/20/1994 | WO1994001547A2 A method for generation of antibodies to cell surface molecules |
| 01/20/1994 | WO1994001546A1 Elicitor of the hypersensitive response in plants |
| 01/20/1994 | WO1994001536A1 Cancer immunotherapy with antibodies to cancer procoagulant |
| 01/20/1994 | WO1994001467A1 Characterization of a novel anti-p110rb monoclonal antibody |
| 01/20/1994 | WO1994001464A1 Leukaemia inhibitory factor-binding protein |
| 01/20/1994 | WO1994001462A1 Biologically active polypeptides derived from an actinomycete |
| 01/20/1994 | WO1994001461A1 BOVINE PANCREATIC TRYPSIN INHIBITOR DERIVED INHIBITORS OF FACTOR Xa |
| 01/20/1994 | WO1994001459A1 A fungicidally active compound |
| 01/20/1994 | WO1994001458A1 Antigenic regions of tumour-liberated particles (tlp) complexes and antibodies against them |
| 01/20/1994 | WO1994001451A2 Method for modification of recombinant polypeptides |
| 01/20/1994 | WO1993023540A3 Improved methods for the preparation of endotoxin-binding proteins |
| 01/20/1994 | CA2140002A1 A chemical method for selective modification of the n- and/or c-terminal amino acid .alpha.-carbon reactive group of a recombinant polypeptide or a portion thereof |
| 01/20/1994 | CA2139945A1 Bovine pancreatic trypsin inhibitor derived inhibitors of factor xa |
| 01/20/1994 | CA2139837A1 A fungicidally active compound |
| 01/20/1994 | CA2139735A1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |
| 01/20/1994 | CA2139573A1 Yeast promoter and its use |
| 01/20/1994 | CA2139572A1 Yeast promoter and its use |
| 01/20/1994 | CA2139504A1 Leukaemia inhibitory factor-binding protein |
| 01/20/1994 | CA2139500A1 Method of determining metastatic potential of tumor cells |
| 01/20/1994 | CA2139431A1 Polypeptides having serotoninergie activity (5ht6), nucleic acids coding for said polypeptides, and uses thereof |
| 01/20/1994 | CA2139345A1 New biologically active polypeptides; preparation and use |
| 01/20/1994 | CA2138646A1 Target antigens of transmission blocking antibodies for malaria parasites |
| 01/20/1994 | CA2137462A1 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
| 01/20/1994 | CA2120954A1 Allergenic proteins and peptides from japanese cedar pollen |
| 01/20/1994 | CA2118585A1 Characterization of a novel anti-p110rb monoclonal antibody |
| 01/20/1994 | CA2117099A1 Receptor derivatives having binding sites for human rhinoviruses |
| 01/19/1994 | EP0578932A2 IL-2 receptor gamma chain molecule |
| 01/19/1994 | EP0578909A1 Human prohibitin and DNA coding for the same |
| 01/19/1994 | EP0578819A1 Icam-related protein |
| 01/19/1994 | EP0578817A1 A dna sequence and encoded polypeptide useful in the diagnosis of hepatitis disease |
| 01/19/1994 | EP0578784A1 Odorant receptors ans uses thereof |